Influenza vaccination in elderly people

Experimental Gerontology

Volumn 34, Issue 3, 1999, Pages 445-452

  Remarque, E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aging; Antibody responses; Influenza; Vaccination

Indexed keywords

INFLUENZA VACCINE;

AGING; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; HEALTH STATUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA VACCINATION; INFLUENZA VIRUS; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED; AGING; ANTIBODIES, VIRAL; HEALTH STATUS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; T-LYMPHOCYTES; VACCINATION;

INFLUENZA VIRUS;

EID: 0033015825     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(99)00007-8     Document Type: Article

References (43)

1. Barker W.H., Mullooly J.P. Influenza vaccination of elderly persons Reduction in pneumonia an influenza hospitalizations and deaths . JAMA. 244:1980;2547-2549.
2. Barker W.H., Mullooly J.P. Impact of epidemic type a influenza in a defined adult population. Am J Epidemiol. 112:1980;798-813.
3. Barker W.H., Mullooly J.P. Pneumonia and influenza deaths during epidemics Implications for prevention . Arch Intern Med. 142:1982;85-89.
4. Barker W.H., Raubertas R., Menegus M., O'Brien D., Freundlich C., Betts R. Case control study of influenza vaccine effectiveness in preventing pneumonia hospitalization among older persons, Monroe County, New York, 1989-1992. Hannoun C., Kendal A.P., Klenk H.D., Ruben F.L. Options for the control of influenza II. 1993;143-151 Elsevier Science, Amsterdam.
5. Beyer W.E.Ph., Palache A.M., Baljet M., Masurel N. Antibody induction by influenza vaccines in the elderly a review of the literature . Vaccine. 7:1989;385-394.
6. Coles F.B., Balzano G.J., Morse D.L. An outbreak of influenza A (H3N2) in a well immunized nursing home population. J Am Geriatr Soc. 40:1992;589-592.
7. D'Alesio D.J., Cox P.M., Dick E.C. Failure of inactivated influenza vaccine to protect an aged population. JAMA. 210:1969;485-489.
8. de Bruijn I.A., Remarque E.J., Beyer W.E.Ph., LeCessie S., Masurel N., Ligthart G.J. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine. 15:1997;1323-1329.
9. de Bruijn I.A., Remarque E.J., Jol-van der Zijde C.M., van Tol M.J.D., Westendorp R.G.J., Knook D.L. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis. 179:1999;31-36.
10. de Greef G.E., van Tol M.J.D., Kallenberg C.G.M., van Staalduinen G.J., Remarque E.J., Tjandra Y.I., Hijmans W. Influence of ageing on antibody formation in vivo after immunisation with the primary T-cell dependent antigen Helix pomatia haemocyanin. Mech Ageing Dev. 66:1992;15-27.
11. Feery B.J., Evered M.G., Morrison E.M. Different protection rates in various groups of volunteers given subunit influenza virus vacine in 1976. J Infect Dis. 139:1979;237-241.
12. Glezen W.P. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 4:1993;25-44.
13. Glezen W.P., Six H.R., Frank A.L., Taber L.H., Perrotta D.M., Decker M. Impact of epidemics upon communities and families. Kendal A.P., Patriarca P.A. Options for the control of influenza. 1986;63-73 Allan Liss, New York.
14. Govaert Th.M.E., Thijs C.T.M.C.N., Masurel N., Sprenger M.J.W., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals A randomized double-blind placebo-controlled trial . JAMA. 272:1994;1661-1665.
15. Govaert Th.M.E., Thijs C.T.M.C.N., Masurel N., Sprenger M.J.W., Dinant G.J., Knottnerus J.A. De effectiviteit van influenzavaccinatie bij ouderen; een gerandomiseerd, dubbelblind, placebo-gecontroleerd onderzoek. Ned Tijdschr Geneesk. 139:1995;2140-2143.
16. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 123:1995;518-527.
17. Gross P.A., Quinnan G.V., Weksler M.E., Gaerlan P.F., Denning C.R. Immunization of elderly people with high doses of influenza vaccine. J Am Geriatr Society. 36:1988;209-212.
18. Gross P.A., Quinnan G.V., Weksler M.E., Setia U., Douglas R.G. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine. 7:1989;303-308.
19. Mäkelä P.H., Jokinen C., Pyhälä R., Mäkelä M., Ruutu P. Use of vaccines for respiratory infections Strategies for influenza and pneumococcal vaccines . Scand J Inf Dis Suppl. 70:1990;141-148.
20. McElhaney J.E., Meneilly G.S., Lechelt K.E., Beattie B.L., Bleackley R.C. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. Vaccine. 11:1993;1055-1060.
21. Meiklejohn G., Hall H. Unusual outbreak of influenza A in a Wyoming nursing home. J Am Geriatr Soc. 35:1987;742-746.
22. Monto A.S., Ohmit S.E., Foster D.A., Furumoto-Dawson A., Arden N.A. Case-control study in Michigan on prevention of hospitalization by vaccination, 1989-1991. Hannoun C., Kendal A.P., Klenk H.D., Ruben F.L. Options for the control of influenza II. 1993;135-141 Elsevier Science, Amsterdam.
23. Mostow S.R., Schoenbaum S.C., Dowdle W.R., Coleman M.T., Kaye H.S. Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ. 41:1969;525-530.
24. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T.L. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 331:1994;778-784.
25. Nicholson K.G., Baker D.J., Chakraverty P., Farquhar A., Hurd D., Kent J., Litton P.A., Smith S.H. Immunogenicity of inactivated influenza vaccine in residential homes for elderly people. Age Ageing. 21:1992;182-188.
26. + T cell differentiation in vivo. Clin Exp Immunol. 96:1994;528-534.
27. Patriarca P.A., Weber J.A., Parker R.A., Hall W.N., Kendal A.P., Bregman D.J., Schonberger L.B. Efficacy of influenza vaccine in nursing homes Reduction in illness and complications during an influenza A (H3N2) epidemic . JAMA. 253:1985;1136-1139.
28. Phair J., Kauffman C.A., Bjornson A., Adams L., Linnemann C. Failure to respond to influenza vaccine in the aged Correlation with B-cell number and function . J Lab Clin Med. 92:1978;822-828.
29. Powers D.C. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. J Med Virol. 43:1994;57-61.
30. Powers D.C., Belshe R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis. 167:1993;584-592.
31. Powers D.C., Belshe R.B. Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: Effects of aging and "original antigenic sin." J Infect Dis. 169:1994;1125-1129.
32. Pyhälä R., Kinnunen L., Kumpulainen V., Ikonen N., Kleemola M., Cantell K. Vaccination-induced HI antibody to influenza A(H1N1) viruses in poorly primed adults under circumstances of low antigenic drift. Vaccine. 11:1993;1013-1017.
33. Remarque E.J., Cools H.J.M., Boere T.J., van der Klis R.J., Masurel N., Ligthart G.J. Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home. Br Med J. 312:1996;1015-1015.
34. Remarque E.J., de Jong J.M.A., Masurel N., Ligthart G.J. Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home residents. Exp Gerontol. 34:(1):1999;109-115.
35. Remarque E.J., Masurel N., Ligthart G.J. Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. J Med Virol. 55:1998;82-87.
36. Remarque E.J., Nijhuis E.W.P., Hinloopen B., Nagelkerken L., van der Velde E.A., Ligthart G.J. Correlation between the antibody response to influenza vaccine and helper T cell subsets in healthy ageing. Vaccine. 14:1996;127-130.
37. Remarque E.J., van Beek W.C.A., Ligthart G.J., Borst R.J.A., Nagelkerken L., Palache A.M., Sprenger M.J.W., Masurel N. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine. 11:1993;649-654.
38. Remarque E.J., Witkamp L., Masurel N., Ligthart G.J. Zinc supplementation does not enhance antibody formation to influenza virus vaccine in the elderly. Aging Immunol Infect Dis. 4:1993;17-23.
39. Sprenger M.J.W., Mulder P.G.H., Beyer W.E.Ph., van Strik R., Masurel N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol. 22:1993;334-340.
40. Sprenger M.J.W., van Naelten M.A.M.G., Mulder P.G.H., Masurel N. Influenza mortality and excess deaths in the elderly, 1967-1982. Epidemiol Inf. 103:1989;633-641.
41. Strassburg M.A., Greenland S., Sorvillo F.J., Lieb L.E., Habel L.A. Influenza in the elderly Report of an outbreak and review of vaccine effectiveness reports . Vaccine. 4:1986;38-44.
42. Sullivan K.M., Monto A.S., Foster D.A. Antibody response to inactivated influenza vaccines of various antigenic concentrations. J Infect Dis. 161:1990;333-335.
43. Tillett H.E., Smith J.W., Gooch C.D. Excess deaths attributable to influenza in England and Wales Age at death and certified cause . Int J Epidemiol. 12:1983;344-352.